Literature DB >> 75857

Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests.

J Bubeník, M Indrová, S Nemecková, M Malkovský, B Von Broen, V Pálek, J Anderlíková.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 75857     DOI： 10.1002/ijc.2910210316

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  13 in total

1.  Induction of specific transplantation immunity by oral immunization with allogeneic cells.

Authors:  V Holán; A Zajícová; M Krulová; J Plsková; J Fric; M Filipec
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

2.  The effect of purification on the immunogenicity of tumor-specific transplantation antigens.

Authors:  T L Saunders; B D Kahan; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases.

Authors:  R Mikysková; J Bubenik; L Mendoza; V Vonka; M Smahel; J Símová; T Jandlová
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Tumour-bearing animals synthesize a decreased level of mRNA for the inducible 55,000 MW interleukin-2 receptor.

Authors:  V Holán; M Lipoldová
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

Review 5.  Noncytolytic extraction of cell surface antigens using butanol.

Authors:  S J LeGrue
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Inhibition of tumor growth in mice treated with synthetic muramyl dipeptide.

Authors:  J Bubeník; J Jezek; M Zaoral; J Hofmann; Y V Gruntenko; J G Osipov; A G Zolotareva; T E Vakhrusheva; V G Budker
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report.

Authors:  J Bubeník; P Perlmann; M Indrová; J Símová; T Jandlová; J Neuwirt
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate.

Authors:  M Malkovský; C Doré; R Hunt; L Palmer; P Chandler; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Tumour inhibitory effects of TCGF/IL-2/-containing preparations.

Authors:  J Bubeník; M Indrová; P Perlmann; K Berzins; O Mach; J Kraml; A Toulcová
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

10.  The anti-tumour efficacy of human recombinant interleukin 2. Correlation between sensitivity of tumours to the cytolytic effect of LAK cells in vitro and their susceptibility to interleukin 2 immunotherapy in vivo.

Authors:  J Bubeník; M Indrová
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.